Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Potential therapeutic targets for scarring hair loss are identified.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

BST2 protein and certain T cells increase in early alopecia areata.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

FoxN1 overexpression in young mice harms immune cell and skin development.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Immune cells affect hair growth and could lead to new hair loss treatments.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Astrotactin2 affects hair follicle orientation and skin cell polarity.